Emerging diabetes technologies: continuous glucose monitors/artificial pancreases
AM Almurashi, E Rodriguez, SK Garg - Journal of the Indian Institute of …, 2023 - Springer
Over the past decade there have been many advances in diabetes technologies, such as
continuous glucose monitors (CGM CGM: A device that measures glucose values in the …
continuous glucose monitors (CGM CGM: A device that measures glucose values in the …
Patient experiences of continuous glucose monitoring and sensor‐augmented insulin pump therapy for diabetes: A systematic review of qualitative studies
P Natale, S Chen, CK Chow, NW Cheung… - Journal of …, 2023 - Wiley Online Library
Aims Blood glucose control is central to the management of diabetes, and continuous
glucose monitoring (CGM) improves glycemic control. We aimed to describe the …
glucose monitoring (CGM) improves glycemic control. We aimed to describe the …
[HTML][HTML] Shaping workflows in digital and remote diabetes care during the COVID-19 pandemic via service design: prospective, longitudinal, open-label feasibility trial
K Braune, K Boss, J Schmidt-Herzel… - JMIR mHealth and …, 2021 - mhealth.jmir.org
Background The COVID-19 pandemic poses new challenges to health care providers and
the delivery of continuous care. Although many diabetes technologies, such as insulin …
the delivery of continuous care. Although many diabetes technologies, such as insulin …
Rollout of closed-loop technology to pregnant women with type 1 diabetes: Healthcare professionals' views about potential challenges and solutions
Aims: To explore healthcare professionals' views about the training and support needed to
rollout closed-loop technology to pregnant women with type 1 diabetes. Methods: We …
rollout closed-loop technology to pregnant women with type 1 diabetes. Methods: We …
Barriers to uptake of Open-Source automated insulin delivery Systems: Analysis of socioeconomic factors and perceived challenges of adults with type 1 diabetes from …
S O'Donnell, D Cooper, Y Chen, H Ballhausen… - Diabetes Research and …, 2023 - Elsevier
Aims Social and technical trends are empowering people with diabetes to co-create or self-
develop medical devices and treatments to address their unmet healthcare needs, for …
develop medical devices and treatments to address their unmet healthcare needs, for …
Tele-education model for primary care providers to advance diabetes equity: findings from Project ECHO Diabetes
A Addala, SL Filipp, LE Figg, C Anez-Zabala… - Frontiers in …, 2022 - frontiersin.org
Introduction In the US, many individuals with diabetes do not have consistent access to
endocrinologists and therefore rely on primary care providers (PCPs) for their diabetes …
endocrinologists and therefore rely on primary care providers (PCPs) for their diabetes …
Cost considerations for adoption of diabetes technology are pervasive: a qualitative study of persons living with type 1 diabetes and their families
Background Cost is a major consideration in the uptake and continued use of diabetes
technology. With increasing use of automated insulin delivery systems, it is important to …
technology. With increasing use of automated insulin delivery systems, it is important to …
Facilitators and barriers to smart insulin pen use: a mixed-method study of multidisciplinary stakeholders from diabetes teams in the United States
This study sought to identify barriers and facilitators to successful smart insulin pen (SIP) use
and gauge prescribing practices and integration into clinical practice by assessing provider …
and gauge prescribing practices and integration into clinical practice by assessing provider …
Youth and non‐European ethnicity are associated with increased loss of publicly funded insulin pump access in New Zealand people with type 1 diabetes
LD Hennessy, M De Lange, EJ Wiltshire… - Diabetic …, 2021 - Wiley Online Library
Aims Continuous subcutaneous insulin infusion (CSII) has been publicly funded in New
Zealand for people living with type 1 diabetes since 2012. The aim of the current study was …
Zealand for people living with type 1 diabetes since 2012. The aim of the current study was …
Barriers to uptake of insulin technologies and novel solutions
ME Pauley, C Berget, LH Messer… - … Devices: Evidence and …, 2021 - Taylor & Francis
Diabetes-related technology has undergone great advancement in recent years. These
technological devices are more commonly utilized in the type 1 diabetes population, which …
technological devices are more commonly utilized in the type 1 diabetes population, which …